全部

1·Proton Pump Inhibitor and Clopidogrel Interaction: Fact or Fiction?

质子泵抑制剂和氯吡格雷的相互作用：是真是假？

2·Esomeprazole, a new proton pump inhibitor, is the S - isomer of omeprazole.

艾司奥美拉唑是一种新型的质子泵抑制剂， 它是奥美拉唑的S - 型光学异构体。

3·Every proton pump inhibitor so far developed is administered in a prodrug form.

迄今为止每个质子泵抑制剂都被研究开发为一个前药的管理形式。

4·This proton pump inhibitor was already approved for adolescents between the ages of 12 to 17.

这种质子泵抑制剂已经被批准用于12岁至17岁的青少年。

5·Proton pump inhibitor (PPI) is considered as the standard treatment for acid-related disorders.

质子泵抑制剂的应用是酸相关疾病的标准治疗。

6·It's the only over-the-counter PPI (proton pump inhibitor) clinically proven to block heartburn for 24 hours.

它是唯一在非处方生产者价格指数(质子泵抑制剂)临床实验证明，阻止24小时胃灼热。

7·Objective to observe the influence of proton pump inhibitor (PPI) esomeprazole on antiplatelet effect of clopidogrel.

目的观察质子泵抑制剂埃索美拉唑是否影响氯吡格雷的抗血小板聚集作用。

8·The present preparation comprises a fixed oral dosage form comprising a proton pump inhibitor in combination with acetyl salicylic acid.

该制剂包括含有质子泵抑制剂与乙酰水杨酸组合的固定的口服剂型。

9·The product contains a patented dual-ingredient formulation that combines the leading prescription acid-reducing medication omeprazole, a proton pump inhibitor, with sodium bicarbonate.

该产品包含一种获得专利的二元混剂，将一线抗酸处方药奥美拉唑(一种质子泵抑制剂)和碳酸氢钠结合。

10·The present invention belongs to the field of medicine preparation, in the concrete, it relates to a composition of substituted benzimidazole proton pump inhibitor and its preparation method.

本发明涉及药物制剂领域，具体涉及含取代苯并咪唑质子泵抑制剂的组合物及其制备方 法。